INSTRUCTIONS Update on pancreatic cancer treatment
* To take the test online, go to our secure Web site at http://www.nursingcenter.com/ce/NP.
* On the print form, record your answers in the test answer section of the CE enrollment form on page 23. Each question has only one correct answer. You may make copies of these forms.
* Complete the registration information and course evaluation. Mail the completed form and registration fee of $21.95 to: Lippincott Williams & Wilkins, CE Group, 2710 Yorktowne Blvd., Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form.
* You will receive your CE certificate of earned contact hours and an answer key to review your results.There is no minimum passing grade.
* Registration deadline is August 31, 2012
DISCOUNTS and CUSTOMER SERVICE
* Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together and deduct $0.95 from the price of each test.
* We also offer CE accounts for hospitals and other healthcare facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Lippincott Williams & Wilkins, publisher of The Nurse Practitioner journal, will award 2.3 contact hours for this continuing nursing education activity.
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.3 contact hours. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #FBN2454.
Your certificate is valid in all states.
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
Update on pancreatic cancer treatment
General Purpose: To provide NPs with current information on the diagnosis and treatment of pancreatic cancer. Learning Objectives: After reading this article and taking this test, the NP will be able to: 1. Identify the incidence, symptoms, and risk factors of pancreatic cancer. 2. Outline treatment strategies for pancreatic cancer.
1. What percentage of pancreatic cancer patients present with advanced or terminal stages at diagnosis?
2. The majority of patients are diagnosed with pancreatic cancer between the ages of
a. 45 and 54.
b. 55 and 64.
c. 65 and 74.
d. 75 and 84.
3. Risk factors for pancreatic cancer include
a. alcohol use.
d. type 1 diabetes mellitus.
4. A common symptom of pancreatic cancer is
a. floating stools.
b. unexplained weight gain.
d. abdominal bloating.
5. In adults 50 years or older, a sudden onset of ____________ may be linked to a possible diagnosis of pancreatic cancer.
a. renal calculi
c. type 2 diabetes
6. Compared with other types of gastrointestinal cancer, which is more common in patients who have pancreatic cancer?
c. alcohol abuse
d. illicit drug use
7. Which is key to establishing the best course of treatment for patients with pancreatic cancer?
b. diagnostic test results
c. provider preference
d. patient preference
8. The only potentially curative treatment for pancreatic cancer is
d. nutrition therapy.
9. For patients with resectable pancreatic cancer tumors, the median survival time is
a. 6 to 12 months.
b. 15 to 19 months.
c. 24 to 30 months.
d. 3 to 5 years.
10. A Whipple procedure may be indicated for patients with a tumor at which location in the pancreas?
a. the head
b. the anterior body
c. the posterior body
d. the tail
11. A common complication following Whipple procedure is
a. early gastric emptying.
12. Which has shown a survival benefit in patients with pancreatic cancer?
a. adjuvant chemotherapy
b. adjuvant chemoradiation
c. nutrition therapy
d. complementary and alternative therapies
13. The NCCN Practice Guidelines for Pancreatic Adenocarcinoma recommend that ______________ be administered with systemic gemcitabine.
c. 5-FU-based CRT
d. no other agents
14. When should adjuvant therapy be initiated in patients with pancreatic cancer?
a. immediately after surgery
b. within 1 to 2 weeks
c. within 3 to 4 weeks
d. within 4 to 8 weeks
15. Which best describes the intent of treatment of advanced pancreatic cancer disease?
b. palliation of symptoms
c. prevention of metastases
d. prevention of complications
16. A common site of pancreatic cancer metastasis is the
17. What is the gold standard of palliative chemotherapy in pancreatic cancer?
d. erlotinib and 5-FU
18. About 75% of patients with advanced pancreatic cancer develop symptomatic
a. gastric outlet obstruction.
b. biliary obstruction.